GlassScriptPhysician profile
Shelley A Killen
NPI 1184798746
$4,014.27
in general payments reported to CMS, 2019-2025
52 companies · $1,017 in 2025
The $1,017 reported for 2025 was more than what 88% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $878 · 2020: $43.80 · 2021: $54.00 · 2022: $639 · 2023: $773 · 2024: $610 · 2025: $1,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,399.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $756.75 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $356.35 | 2019-2025 | Strensiq, Ultomiris |
| Ucb, INC. | $267.75 | 2019-2025 | Cimzia, Bimzelx |
| Novartis Pharmaceuticals Corporation | $244.39 | 2019-2025 | |
| Amgen INC. | $232.60 | 2019-2025 | Evenity, Prolia, Tavneos |
| Eisai INC. | $155.23 | 2023-2025 | |
| Allergan, INC. | $142.19 | 2019-2022 | |
| Janssen Biotech, INC. | $134.13 | 2022-2025 | Tremfya, Simponi Aria |
| Biogen, INC. | $131.46 | 2019-2025 | Vumerity |
| Merz North America, INC. | $99.42 | 2019 | |
| Nevro Corp. | $99.28 | 2023 | Senza |
| Medtronic, INC. | $95.88 | 2022 | |
| Pfizer INC. | $73.31 | 2023-2024 | |
| Lundbeck LLC | $65.34 | 2022-2025 | Rexulti, Vyepti |
| Acadia Pharmaceuticals INC | $64.77 | 2020-2024 | Nuplazid |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelley Killen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.